Detalhe da pesquisa
1.
Health state utility values in major depressive disorder treated with pharmacological interventions: a systematic literature review.
Health Qual Life Outcomes
; 19(1): 94, 2021 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33736649
2.
Cost Effectiveness of Gemtuzumab Ozogamicin in the First-Line Treatment of Acute Myeloid Leukaemia in the UK.
Pharmacoecon Open
; 5(4): 677-691, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34181204
3.
Budget Impact Analysis of Gemtuzumab Ozogamicin for the Treatment of CD33-Positive Acute Myeloid Leukemia.
Pharmacoeconomics
; 39(1): 121-131, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33236329
4.
Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain.
Clinicoecon Outcomes Res
; 13: 263-277, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33911887
5.
Economic Evaluations of New Oral Anticoagulants for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement: A Systematic Review.
Pharmacoeconomics
; 35(5): 517-535, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28185212